The artificial pancreas

Diabetes

Volumn 61, Issue 9, 2012, Pages 2221-2224

  Radziuk, Jerry ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN LISPRO;

ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; DRUG ABSORPTION; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MATHEMATICAL MODEL; NOTE; PRIORITY JOURNAL; STOMACH EMPTYING;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN INFUSION SYSTEMS; PANCREAS, ARTIFICIAL;

EID: 84865448017     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0647     Document Type: Note

References (20)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. Albisser AM, Leibel BS, Ewart TG, et al. Clinical control of diabetes by the artificial pancreas. Diabetes 1974;23:397-404
3. Pfeiffer EF, Thum CH, Clemens AH. The artificial beta cell-a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 1974;6:339-342
4. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes 1974;23:389-396
5. Breton M, Farret A, Bruttomesso D, et al. Fully integrated artificial pancreas in type 1 diabetes. Modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237
6. Wang Y, Percival MW, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd. A novel adaptive basal therapy based on the value and rate of change of blood glucose. J Diabetes Sci Tech 2009;3:1099-1108
7. Kovatchev B, Patek S, Dassau E, et al.; Juvenile Diabetes Research Foundation Artificial Pancreas Consortium. Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Tech 2009;3:1058-1065
8. Watson EM, Chappell MJ, Ducrozet F, Poucher SM, Yates JWT. A new general glucose homeostatic model using a proportional-integral-derivative controller. Comput Methods Programs Biomed 2011;102:119-129
9. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939
10. Magni L, Forgione M, Toffanin C, et al. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial. J Diabetes Sci Tech 2009;3:1091-1098
11. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 2002;45:937-948 (Pubitemid 34762188)
12. Pettis RJ, Ginsberg B, Hirsch L, et al. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther 2011;13:435-442
13. Castle JR, Engle JM, El Youssef J, et al. Novel use of glucagon in a closedloop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010;33:1282-1287
14. Russell SJ, El-Khatib FH, Nathan DM, Damiano ER. Efficacy determinants of subcutaneous microdose glucagon during closed-loop control. J Diabetes Sci Tech 2010;4:1288-1304
15. Hovorka R, Canonico V, Chassin LJ, et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 2004;25:905-920 (Pubitemid 39121173)
16. Radziuk J, Barron P. Does pancreatic portal venous drainage matter? In Diabetes Annual/9. Marshall SM, Home PD, Rizza R, Eds. Amsterdam, Elsevier, 1995, p. 141-158
17. Radziuk J, Pye S, Seigler DE, Skyler JS, Offord R, Davies G. Splanchnic and systemic absorption of intraperitoneal insulin using a new double-tracer method. Am J Physiol 1994;266:E750-E759
18. Schade DS, Eaton RP, Friedman NM, Spencer WJ, Standefer JC. Five-day programmed intraperitoneal insulin delivery in insulin-dependent diabetic man. J Clin Endocrinol Metab 1981;52:1165-1170 (Pubitemid 13237520)
19. Liebl A, Hoogma R, Renard E, et al.; European Diaport Study Group. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obes Metab 2009;11:1001-1008
20. Renard E, Place J, Cantwell M, Chevassus H, Palerm CC. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Diabetes Care 2010;33:121-127